# Gut Microbiota (GM) Biodiversity in Patients With Solid Tumors Treated With Immune Checkpoint Inhibitors (ICIs): a Monocenter Prospective Study to Identify the Interactions Between GM and ICIs

> **NCT07236983** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 70 (estimated)

## Conditions studied

- Solid Tumor Cancer Treatment With Immunotherapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07236983
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-27
- **Primary completion:** 2025-08-31
- **Final completion:** 2026-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07236983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07236983, "Gut Microbiota (GM) Biodiversity in Patients With Solid Tumors Treated With Immune Checkpoint Inhibitors (ICIs): a Monocenter Prospective Study to Identify the Interactions Between GM and ICIs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07236983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*